Skip to content

NeuroBlate System

by Monteris Medical Inc

510(k) K131955

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK131955 Date30 Jul 2013ClearedStatusActive

Official records

From the FDA record

Received by the FDA
27 Jun 2013
FDA decision
30 Jul 2013 (Substantially Equivalent)
FDA review time
33 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K131955 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-0228-2015 FDA Class II initiated 3 Oct 2014
    • Terminated Z-0227-2015 FDA Class II initiated 3 Oct 2014

    Monteris Medical received a complaint of a separation of the distal sapphire tip from the laser delivery probe.

Timeline

3 dated events

  1. Cleared FDA 510(k) K131955
  2. Recall initiated FDA recalls Z-0228-2015
  3. Recall initiated FDA recalls Z-0227-2015

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Neuroblate(Tm) System
510(k) Number
FDA product code
GEX
FDA applicant
Monteris Medical, Inc.
Device class
Class II
Regulation
21 CFR Part 878.4810
Advisory committee
General, Plastic Surgery
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The NeuroBlate System is a robotic, MRI-guided laser ablation device designed for interstitial thermal therapy (LITT) in the brain. It is classified as a laser ablation system for neurosurgical applications, enabling precise, minimally invasive treatment of brain lesions, including tumors, radiation necrosis, and epilepsy foci. The device delivers focused laser energy under real-time MRI visualization to achieve targeted tissue ablation without the need for open neurosurgery. Its design integrates robotic guidance and thermal monitoring to enhance accuracy and safety during procedures.

The NeuroBlate System is supplied as a reusable medical device intended for use in sterile operating environments, such as neurosurgical suites equipped with MRI capabilities. It is regulated under FDA 510(k) clearance (K131955) and is classified under product code GEX for general plastic surgery applications. The system requires compatibility with MRI-compatible surgical settings and is intended for single-patient use per procedure. Storage and handling follow standard sterile medical device protocols to maintain device integrity and performance.

Similar devices

Other devices filed under FDA product code GEX (Powered Laser Surgical Instrument).

Other devices from Monteris Medical Corp

See all devices from Monteris Medical Corp →